How does Sitagliptin compare to GLP-1 receptor agonists for managing weight and glycemic control in patients with comorbid obesity?
Sunil JoshiExplorer
How does Sitagliptin compare to GLP-1 receptor agonists in comorbid obesity?
Share
Sitagliptin, a DPP-4 inhibitor, generally has a neutral effect on weight, whereas GLP-1 receptor agonists often promote significant weight loss and generally provide better glycemic control.